参考文献/References:
[1] Louvet A,Mathurin P.Alcoholic liver disease:mechanisms of injury and targeted treatment[J].Nat Rev Gastro Hepat,2015,12(4):231-242.
[2] O'shea R S,Dasarathy S,Mccullough A J.Alcoholic liver disease[J].Hepatology,2010,51(1):307-328.
[3] Hayashi H,Sudo H.Economic importance of licorice[J].Plant Biotechnol-Nar,2009,26(1):101-104.
[4] Ming L J,Yin A.Therapeutic effects of glycyrrhizic acid[J].Nat Prod Commun,2013,8(3):415-418.
[5] 张丽平,梁玉玲,许恒飞.胀果甘草细胞的悬浮培养[J].河北大学学报:自然科学版,2008,28(6):659-663.
[6] Negishi M,Irie A,Nagata N,et al.Specific binding of glycyrrhetinic acid to the rat liver membrane[J].Biochim Biophys Acta,1991,1066(1):77-82.
[7] Li Jianyuan,Cao Hongyan,Liu Ping,et al.Glycyrrhizic acid in the treatment of liver diseases:Literature review[J].Biomed Res Int,2014,2014(8):872139.
[8] Guo Xiaoling,Liang Bo,Wang Xuewei,et al.Glycyrrhizic acid attenuates CCl4-induced hepatocyte apoptosis in rats via a p53-mediated pathway[J].World J Gastroenterol,2013,19(24):3781-3791.
[9] Jeong H G,You H J,Park S J,et al.Hepatoprotective effects of 18β-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome p450 2E1 expression[J].Pharmacol Res,2002,46(3):221-227.
[10] Ukil A,Biswas A,Das T,et al.18β-Glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-κB[J].Journal of Immunology,2005,175(2):1161-1169.
[11] Wu Xudong,Zhang Luyong,Gurley E,et al.Prevention of free fatty acid-induced hepatic lipotoxicity by 18beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways[J].Hepatology,2008,47(6):1905-1915.
[12] Xiao Yichuan,Xu Jingwei,Mao Chaoming,et al.18β-glycyrrhetinic acid ameliorated propionibacterium acnes-induced acute liver injury through inhibition of MIP-1α[J].Journal of Biological Chemistry,2009,285(2):1128-1137.
[13] Zeng Chunxiang,Yang Qing,Hu Qin.A comparison of the distribution of two glycyrrhizic acid epimers in rat tissues[J].European Journal of Drug Metabolism & Pharmacokinetics,2006,31(4):253-258.
[14] Zou Qiaogen,Wei Ping,Li Jing,et al.Simultaneous determination of 18α- and 18β-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics[J].Biomedical Chromatography Bmc,2009,23(1):54-62.
[15] 赵燕燕,石敏健,刘丽艳,等.4代甘草酸制剂主成分异构体及有关物质含量差异分析与变化趋势[J].药物分析杂志,2014,34(2):247-254.
[16] 杨文东,纪永利,赵登贤.脂肪肝患者血清胆碱酯酶水平观察[J].检验医学,2000,15(1):33.
[17] Ding Wenxiao,Zhang Qiang,Dong Yanbin,et al.Adiponectin protects the rats liver against chronic intermittent hypoxia induced injury through AMP-activated protein kinase pathway[J].Scientific Reports,2016,6:34151-34162.
[18] Rogers C Q,Ajmo J M,You M.Adiponectin and alcoholic fatty liver disease[J].Iubmb Life,2008,60(12):790-797.
[19] Yamauchi T,Kamon J,Minokoshi Y,et al.Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase[J].Nat Med,2002,8(11):1288-1295.